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Abstract
Background: To maintain populations of microbial cells under controlled conditions of growth
and environment for an indefinite duration is a prerequisite for experimentally evolving natural
isolates of wild-type species or recombinant strains. This goal is beyond the scope of current
continuous culture apparatus because these devices positively select mutants that evade dilution,
primarily through attachment to vessel surfaces, resulting in persistent sub-populations of
uncontrollable size and growth rate.
Results: To overcome this drawback, a device with two growth chambers periodically undergoing
transient phases of sterilization was designed. The robustness of this device was assessed by
propagating an E. coli strain under permanent thymine starvation for over 880 days, i.e. metabolic
conditions notoriously known to lead to cell death and clogging of cultivation vessels. Ten thousand
generations were required to obtain a descendant lineage that could resist thymine starvation and
had recovered wild-type growth rate.
Conclusions:  This approach provides a technological framework for the diversification and
improvement of microbial strains by long-term adaptation to inescapable metabolic constraints. An
E. coli strain that is totally resistant to thymineless death was selected.
Background
Experimental evolution of microorganisms is a field of
vast potential for both fundamental and industrial pur-
poses. Genetic engineering masters the modular assem-
bly of genes and their products, but it is by selecting for
the enhancement of the overall fitness of recombinant
organisms that we can most readily improve the func-
tional integration of such assemblies. Studies of experi-
mental evolution have, however, been hindered by
difficulties maintaining large populations of microbial
cells under controlled internal and external conditions
for numerous generations.
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The long-term proliferation of microorganisms is cov-
ered by a body of knowledge known as continuous cul-
ture [1,2], technically and theoretically established
around the equivalent Monod's bactogene [3] and
Novick's and Szilard's chemostat [4]. Basically, these de-
vices operate by renewing a liquid culture of constant
volume with nutrient medium inflow, such that microbes
must counteract dilution by growing at least at an equal
rate [1,2]. Mutants proliferating at higher growth rates
are selected during prolonged operation of these devices
[1,2].
The advantages of continuous culture systems to per-
form experimental evolution studies (control, mathe-
matical modeling, absence of bottle-necks, high number
of generations per day) were discussed previously by sev-
eral authors [3,5,6]. However, various undesired surviv-
al mechanisms can predominate in continuous cultures
through attachment to the culture vessel and selection of
static variants evading dilution rather than overcoming
it [7,8]. This phenomenon is often referred to as wall
growth [1,2,6]. For these reasons, the most extensive ex-
periment of microbial adaptation to the laboratory re-
ported so far (20000 generations of E. coli growth
during 10 years) was conducted by manual serial sub-
culturing in common microbiology glassware and not by
automated propagation in continuous culture equip-
ment [9–11].
To overcome many of the drawbacks of continuous cul-
ture, a device with two growth chambers that preserves a
proliferating culture while subjecting all parts in contact
with the culture to transient sterilization over its opera-
tion cycle, was designed and constructed. In effect, ad-
herence is actively counter-selected in the device, and
cell populations can be propagated in suspension for in-
definitely long duration. This device was utilized for 880
days to evolve a thymine-requiring E. coli strain under
limiting thymine supply. Shortage of thymine is known
to entail cell lysis in E. coli[12] and proves challenging in
continuous cultures because debris can rapidly clog fer-
menter tubing, thereby stopping operations. Thymine
starvation provides an experimentally convenient means
to maintain a metabolic constraint on the structure of the
E. coli genome. In order to reduce the amount of dTMP
required for cell division, three mechanisms can be an-
ticipated: 1) Iterative substitution of TA or AT pairs to GC
or CG pairs eventually yielding a GC rich genome as in
the evolution of the mutT strain [13]. 2) Iterative deletion
of non-essential genes to eventually yield a trimmed ge-
nome. 3) Incorporation of an ersatz of dTMP during
DNA polymerization, e.g. dUMP [14,15] or 5-hy-
droxymethyluracil [16] eventually yielding chemically
remodeled genomic material. Assessing the occurrence
of such evolutionary processes, in real time, would be of
interest in any of these cases.
Results and discussion
Automated cultivation setup
In principle, an ever-clean chemostat could be set up by
periodically swapping a culture between two growth
chambers that are symmetrically connected and
equipped with independent inflow and outflow lines. An
automated device implementing this procedure with a
dozen electrovalves for controlling the fluid traffic is de-
scribed by Marlière and Mutzel [17]. In the course of
elaboration of this device, a simpler apparatus using only
five electrovalves was set up to be subjected to hard case
testing. It consists of two growth chambers between
which the nutrient flow is periodically reversed (Fig. 1).
A constant nutrient flow runs through an upstream
growth chamber and then through a downstream growth
chamber of identical volume before exiting the device.
When a massive dose of sterilizing agent is briefly inject-
ed in the line bridging the left and right chambers of the
setup, all cells of one chamber (downstream) are de-
stroyed without affecting those in the second chamber
(upstream). Following this episode continued overflow
from the upstream chamber restores viable conditions in
the downstream chamber by diluting out the lethal agent
and replenishing it with living cells from the upstream
chamber. At this stage, the nutrient flow can be reversed,
Figure 1
Operation cycle of an alternating tandem chemostat.
Wavy lines, dots and circles in growth chambers represent
culture level, live bacteria and air bubbling respectively. The
letters 0 and X indicate open and closed valves, respectively.
Lines carrying mixed gaseous-liquid flows are in bold. In the
tube that connects the two chambers, the dotted arrow indi-
cates the direction of flow. Sterilization and replenishment
phases have respective durations of 20 mn and 47 h 40 mn.
During each cycle, both growth chambers, their effluent lines
and the bridging line are transiently flooded with 10 N
NaOH, destroying all cells attached to any part of the device.
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such that the sterilization process can be repeated with
the second chamber. Cyclic inversion of nutrient flow,
followed by injection of the lethal agent ensures that all
parts of the device in contact with the cultivated organ-
ism are sterilized in turn (Fig. 1). Cells that proliferate ex-
clusively by attaching to or remaining in any part of the
vessel are completely destroyed during each operation
cycle, thus actively counter-selecting static variants. In
contrast, cells that perfectly disperse in suspension are
not subject to destruction by the sterilizing agent and
flow freely from one chamber to the other. This appara-
tus allows to really implement experimental evolu tion
protocols as selective conditions can be maintained for
an indefinite period of time.
Concentrated sodium hydroxide was chosen as the steri-
lizing agent because of its insuperable killing potency
against bacterial cells, its high potency for cleaning ves-
sel surfaces, and its ready disposability under non-pol-
luting form. The choice of concentrated alkaline
solutions also seemed pertinent for confining recom-
binant organisms and containing the dissemination of
genetic markers, as such solutions degrade nucleic acids
to nucleosides.
Genetic setup for thymine limitation
Shortage in thymine entails rapid lethality in living cells
[12,18]. In E. coli it can be enforced irreversibly by a de-
letion of thyA, the gene encoding thymidylate synthase,
which cannot be suppressed by any known mutation
[19]. The E. coli strain β 7328 of genotype ∆ thyA ∆ deo-
CABD p::deoA+ lacking thymidylate synthase, phospho-
deoxyribose aldolase, phosphodeoxyribose isomerase
and overproducing thymidine phosphorylase was con-
structed (as described in the protocol section) to enforce
an absolute requirement for low concentrations of exog-
enous thymine (Fig. 2) : a minimum of 5 µM (1.25 µg/ml)
thymine was necessary for optimal proliferation. Batch
cultivation with 1 µM (0.25 µg/ml) thymine resulted in a
brief episode of growth followed by death and accumula-
tion of cell debris. These values match those published
for low thymine-requiring auxotrophic mutants carrying
mutations in thyA and either in deoB or deoC[20].
Overcoming thymineless death
Strain β 7328 was used to inoculate a culture in MS min-
imal medium containing 10 mM glucose and 1 µM thym-
ine at 37°C; this culture was transferred in the device
described above. The dilution rate (setting the genera-
tion time) was set to four hours during the first month
and two hours thereafter. Over the first 30 days, the pop-
ulation underwent a regime of wide oscillations in bacte-
rial density (data not shown), reflecting episodes of
growth and lysis due to thymine shortage. The thymine
auxotrophic population proliferating in the device then
underwent a progressive increase in biomass, from an
OD (A600nm) lower than 0,005 to an OD of 1.2 reaching
a plateau at around 1700 generations (Fig. 3). Biomass
oscillated around 0.955 OD (A600nm) until generation
7500 and then oscillated around an OD of 1.1 until the
culture was stopped after having been maintained for
880 days and just over 10000 generations. All descend-
ent strains isolated from the chemostat culture were still
thymine auxotrophs, demonstrating that no novel bio-
synthetic pathway to dTTP arose over the course of the
experiment. Six samples corresponding to generations
1710 (γ 1710), 3330 (γ 3330), 5010 (γ 5010), 5982 (γ 5982),
6930 (γ 6930), and 8094 (γ 8094) respectively, were further
analyzed.
Phenotypes of the descendents
In order to estimate the number of mutations accumulat-
ed in the descendents, the capacity to utilize 100 differ-
ent carbon sources was monitored (Table 1). A
progressive loss of metabolic capabilities was observed
with passing generations. These phenotypes were con-
firmed by comparing the growth of the input and output
Figure 2
Thymine and thymidine metabolism in strain β 7328
(∆ deoCABD thyA::Erm p::deoA+) Abb.: dR1P, deoxyribose-1-
phosphate; dR5P, deoxyribose-5-phosphate, T, thymine; dT,
thymidine; dUMP, uridilate; dTMP, thymidilate; dTDP.
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strains on solid minimal medium containing 0.2% of the
different carbon sources. Fifty individual clones isolated
from each sample were found to be genetically homoge-
neous, suggesting that the output populations were clon-
al at different sampling times. Monophyletism of the
chemostat population was therefore postulated hereaf-
ter. After 1722 generations, 15 substrates out of 100 test-
ed could no longer be utilized. If the tested phenotypes
were independent as assumed in Table 1, this would give
a 15% observed probability of pathway inactivation. The
phenotypes are clearly not independent. For example, a
mutation in the dct gene, encoding for the dicarboxylate
transport, could be responsible for the growth deficien-
cies of the descendents on malate, succinate and aspar-
tate [21]. Examination of the pathways for the 15
substrates [22], suggest that 8 phenotypes must be
caused by independent mutations. A similar analysis of
the 100 phenotypes tested yields an estimate of 60 inde-
pendent phenotypes. As 15/100 and 8/60 give similar
values we decided to make the assumption of independ-
ence. We can therefore estimate that 20 to 200 times
more mutations are observed than expected from genetic
drift (Table 1). In the following generations (except be-
tween γ 3330 and γ 1710), the observed mutation probabili-
ty is just slightly higher then the predicted (Table 1).
These estimations suggest that the accumulation of mu-
tations is a selected trait in the first 2000 generations,
but it remains to be det ermined by closer studies if this
trait is still selected from 2000 onwards. It is clear from
these results that most catabolic losses occurred in the
early stages of the evolution experiment as previously
observed by Cooper and Lenski [11]. This progressive
loss of traits could be caused either by T substitutions or
T deletions as discussed earlier. The identification of the
type of inactivating mutation (deletion or substitution)
will be the object of a separate report once the genomes
of the evolved strains have been resequenced. Survival
via replacement of dTMP by dUMP was not observed and
might need further commitment in the construction of a
strain containing the dut ung alleles encoding dUTPase
and Uracil-DNA-glycosylase respectively [14,15], so that
misincorporated U's are not repaired.
Viability parameters
It has been shown both experimentally and theoretically
that in a chemostat limited for a substrate S, a mutant
with higher growth rate (usually by a higher affinity for
substrate) will quickly overtake the population [23]. In
the thymine-limited chemostat, substrate is so limiting
that a sub-population of the cells is dying at all times. A
simple approximation of this situation has been treated
by Kubitschek [1] by introducing a death rate in the clas-
sical chemostat equations and is summarized below. If
two descendents i and j are in competition in the chemo-
stat, xi and xj represent their respective biomass, α i and
α j their respective growth rates, θ i and θ j their respective
death rates and ω  the dilution rate then:
After integration
It follows 
One sees that j will outgrow i if
α j - θ j > α i - θ i
By analogy with the classical expression of Monod's law
for growth rate, a simple relation between death rate and
the concentration of the limiting substrate would be:
We then approximated the values of α max and θ max from
the output cultures isolated from the chemostat. α max
was estimated by monitoring the growth rates of the out-
Figure 3
10000 generations in a thymine limiting (1 µM) che-
mostat. The OD (A600nm) was measured by sampling.
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put strains in batch cultures at high thymine concentra-
tions (10 µM) and θ max by monitoring death rate in the
absence of thymine. As shown in Fig. 4, the more gener-
ations elapsed, the more resistant the descendants be-
came to thymineless death until γ 6930 and γ 8094 became
totally resistant to thymine shortage. Concomitantly, the
maximum growth rate in the presence of excess thymine
decreased by 50% in γ 1710. The growth of this strain is
hardly superior to the dilution rate as shown in Fig. 4.
Should it have been lower, the evolvant would have not
been maintained and would have been eliminated by di-
lution. Then, a gradual increase in maximum growth rate
was observed in the descendents until the initial maxi-
mum growth rate of β 7328 was recovered in β 6930 (4).
Conclusions
Directed evolution was automatically conducted for 880
days under permanent metabolic constraint using a new
continuous culture device that enables selection of E. coli
strains that are totally resistant to thymineless death.
Thus, a long awaited tool allowing strain improvement
by experimental evolution has been constructed and suc-
cessfully tested. The systematic elimination of static var-
iants that escape dilution by attaching to the vessel now
allows the possibility to maintain cultures under defined
conditions indefinitely. Chemostats shorten the time of
long term experiments, compared to manual transfer,
and can be easily automated so that many cultures are
conducted in parallel. The automation and robustness of
the device should allow many applications in the bio-
technology field.
Materials and methods
Strains and growth conditions
Bacteria were routinely grown in mineral standard (MS)
medium [24] containing 2 g glucose/liter with or without
thymine (1 to 10 µM) or in LB medium [25]. Growth me-
dia were solidified with 15 g/liter agar (Difco) for the
preparation of plates. Transformations and PI transduc-
tions were performed following standard procedures
[25,26]. The utilization of 100 carbon sources was tested
using the ApiBiotype100™ system (BIO-MERIEUX),
under conditions recommended by the manufacturer.
Strain β 2033 [27] was used for cloning. Strain β 7328 was
Table 1: Carbon source utilization by β 7328 and descendents
Strains and generations
Substrates β 7328 γ 1710 γ 3330 γ 5010 γ 8094
- -- - - -
M a n n o s e + +++-
D(+) Galactose + + + - -
1-0-Methyl-β -Galactopyranoside + + + - -
m-Coumarate + + + - -
1-0-Methyl-β -glucopyranoside + - - - -
α -L-(-) Fucose + - - - -
Mucate + - - - -
L ( + ) - T a r t r a t e + ----
L(-)-malate + - - - -
D(+)-Malate + - - - -
5-Keto-D-gluconate + - - - -
Succinate + - - - -
DL-Glycerate + - - - -
L-Aspartate + - - - -
L - P r o l i n e + ----
L-Alanine + - - - -
L-serine + - - - -
propionate + - - - -
α -Ketoglutarate + - - - -
Calculated pathway inactivation probability by genetic drift 0.085–0.85% 0.079–0.79% 0.082–0.82% 1.02%
Observed pathway inactivation probability (under assumption of independence) 15/100 15% 0/85 0% 3/85 3.5% 1/82 1.2%
 Growth on 100 different carbon sources was monitored using API100™ kits (Bio-merieux). Observed phenotypes are designated by +(growth) 
and – (no growth). The mutation probabilities were calculated as follows: an average pathway for carbon source utilization contains from 1 to 10 
pathway specific genes (10 to 104 bp). The mutation rate per bp per generation in E. coli is 5.4 10-10[30] and if the assumption is made that every 
mutation is inactivating (which is the most conservative hypothesis), the probability of acquiring a mutation in a given pathway after X generations 
by genetic drift is X 5.4 10-10 103 or 4. As the mannose-deficient-phenotype can be due to a mutation in manA, manXYZ or, nagC corresponding to 
4128 bp [31], this value was used for the mutation probability between γ 5010 and γ 8094.BMC Biotechnology 2001, 1:10 http://www.biomedcentral.com/1472-6750/1/10
constructed as follows. The thyA::erm+ marker from
β 1308 [19] was introduced by PI transduction in the ∆ de-
oCABD strain β 7077 [28], selecting for erythromycin re-
sistance (400 µg/ml) in the presence of 300 µM
thymidine. Next, the ∆ deoCABD thyA::erm+ strain was
transformed with p::deoA+ to give β 7328 used to inocu-
late the chemostat.
Cloning of the E. coli deoA gene
The p::deoA+ plasmid was constructed as follows. A 1.3
kb fragment containing the deoA gene was PCR ampli-
fied from MG1655 chromosomal DNA using the follow-
ing oligonucleotides: ol1 gcgcccgggaggttaccttgtttct, ol2
gcggaattcgttattcgctgatacggcgat and standard conditions
using Vent™ Polymerase (New England Biolabs, Bever-
ley MA). The fragment was digested by SmaI and EcoRI
and cloned into pTZ19 (Pharmacia) digested by the same
restriction enzymes. p::deoA+ plasmid was verified by
sequencing and allowed the ∆ deoABCD ∆ thyA strain to
use thymine as a thymidine source (Fig. 2).
Chemostat operation
An alternating tandem chemostat was implemented us-
ing continuous culture modules [17] elaborating on pub-
lished techniques [29,6]. Thus, twin growth chambers of
the bubble-column type [4], each holding a 20-ml cul-
ture were set up in glass tubing connected with Teflon
and silicon rubber lines and placed in thermostated
blocks. Sterile nutrient flows from a pressurized Mariot-
te reservoir (0.3 bar atmospheric pressure) were regulat-
ed by capillary Teflon tubing [1,29], mixed with sterile
airflow, and injected at the bottom of the growth cham-
ber within the culture [7]. Flows in the nutrient and efflu-
ent lines were controlled by an array of pinch valves
connected to an automaton (both purchased from Bürk-
ert GmbH, Germany). The flow of sterile air was not sub-
ject to control and maintained in both chambers without
interruption. The device was also equipped with a valve-
controlled line delivering 10 N NaOH in the line bridging
the two growth chambers. Restoration of the growth con-
ditions was effected by continued dilution of the down-
stream chamber with the outflow of the upstream
chamber. Sterilization phases were programmed to recur
at the highest frequency compatible with a safe propaga-
tion of the culture, i.e. one nutrient flow reversal and one
sterilization phase per 48 h for a 2-h generation time.
The equations for growth in a two-stage single stream
chemostat with chambers of identical volume (P. Mar-
lière, unpublished results) showed that the value for the
growth rate at equilibrium is the dilution rate like in a
classical chemostat [23]. The population size can be esti-
mated to 1010, knowing that the vessel holds 20 ml of
bacterial culture and the OD (A600 nm) oscillated
around the value of 1 which corr esponds to 5 108 cells/
ml.
Determination of growth rates and death rates
Growth rates were determined by measuring the optical
density (A600nm) of at least five successive samples taken
from cultures in balanced growth in MS glucose medium
supplemented with 10 µM thymine at 37°C. Single clones
reisolated after plating the output samples were used.
Death rates were determined as follows. Cells grown in
MS glucose supplemented with 10 µM thymine were har-
vested in late exponential phase, washed three times
with MS and used to inoculate 50 ml of MS glucose. At
different time points aliquots were taken and viable
counts were measured by plating dilutions on MS glu-
cose/10 µM thymine. Death rates were measured by ap-
proximating a linear decrease in viability between 1 and
3 hours.
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